Novel motif:115: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:09, 9 September 2013
name: | motif115_CATCAACTAC |
---|
![](/5/sstar/seqlogos/novel/115.png)
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0044243 | multicellular organismal catabolic process | 1.302278e-11 |
GO:0030029 | actin filament-based process | 1.004446e-10 |
GO:0006434 | seryl-tRNA aminoacylation | 1.791068e-10 |
GO:0030036 | actin cytoskeleton organization | 2.023523e-10 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 2.936352e-10 |
GO:0071173 | spindle assembly checkpoint | 3.862465e-10 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 4.078152e-10 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 5.938973e-10 |
GO:0031577 | spindle checkpoint | 6.262653e-10 |
GO:0018350 | protein esterification | 2.229112e-9 |
GO:0044258 | intestinal lipid catabolic process | 2.229112e-9 |
GO:0015891 | siderophore transport | 2.229112e-9 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 2.400416e-9 |
GO:0044240 | multicellular organismal lipid catabolic process | 3.366800e-9 |
GO:0014866 | skeletal myofibril assembly | 8.709026e-9 |
GO:0045839 | negative regulation of mitosis | 8.802602e-9 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 9.099056e-9 |
GO:0030261 | chromosome condensation | 1.696368e-8 |
GO:0003012 | muscle system process | 3.026763e-8 |
GO:0000075 | cell cycle checkpoint | 8.449988e-8 |
GO:0031397 | negative regulation of protein ubiquitination | 1.031398e-7 |
GO:0048769 | sarcomerogenesis | 1.075865e-7 |
GO:0030240 | skeletal muscle thin filament assembly | 1.338373e-7 |
GO:0007076 | mitotic chromosome condensation | 1.535126e-7 |
GO:0006418 | tRNA aminoacylation for protein translation | 2.048701e-7 |
GO:0048739 | cardiac muscle fiber development | 2.268367e-7 |
GO:0055003 | cardiac myofibril assembly | 2.830890e-7 |
GO:0071732 | cellular response to nitric oxide | 2.904368e-7 |
GO:0007093 | mitotic cell cycle checkpoint | 2.908900e-7 |
GO:0030149 | sphingolipid catabolic process | 3.355344e-7 |
GO:0035051 | cardiac cell differentiation | 3.919059e-7 |
GO:0044236 | multicellular organismal metabolic process | 4.121927e-7 |
GO:0046514 | ceramide catabolic process | 4.533808e-7 |
GO:0006936 | muscle contraction | 5.089098e-7 |
GO:0071156 | regulation of cell cycle arrest | 5.455927e-7 |
GO:0046466 | membrane lipid catabolic process | 6.451822e-7 |
GO:0051592 | response to calcium ion | 9.273055e-7 |
GO:0072560 | type B pancreatic cell maturation | 9.289160e-7 |
GO:0007015 | actin filament organization | 9.304136e-7 |
GO:0031532 | actin cytoskeleton reorganization | 9.959978e-7 |
GO:0043589 | skin morphogenesis | 1.080516e-6 |
GO:0055007 | cardiac muscle cell differentiation | 1.275684e-6 |
GO:0010927 | cellular component assembly involved in morphogenesis | 1.455466e-6 |
GO:0046521 | sphingoid catabolic process | 1.703785e-6 |
GO:0055013 | cardiac muscle cell development | 1.770596e-6 |
GO:0006323 | DNA packaging | 2.253495e-6 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 2.335489e-6 |
GO:0060285 | ciliary cell motility | 2.416632e-6 |
GO:0043039 | tRNA aminoacylation | 2.453933e-6 |
GO:0000819 | sister chromatid segregation | 3.276006e-6 |
GO:0000070 | mitotic sister chromatid segregation | 3.747001e-6 |
GO:0043004 | cytoplasmic sequestering of CFTR protein | 4.838385e-6 |
GO:0043353 | enucleate erythrocyte differentiation | 5.302873e-6 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 5.420710e-6 |
GO:0042363 | fat-soluble vitamin catabolic process | 5.516750e-6 |
GO:0030157 | pancreatic juice secretion | 6.247412e-6 |
GO:0006768 | biotin metabolic process | 6.530511e-6 |
GO:0006552 | leucine catabolic process | 6.530511e-6 |
GO:0015696 | ammonium transport | 7.047155e-6 |
GO:0070682 | proteasome regulatory particle assembly | 7.140410e-6 |
GO:0030239 | myofibril assembly | 7.918839e-6 |
GO:0050658 | RNA transport | 8.979104e-6 |
GO:0006941 | striated muscle contraction | 9.017691e-6 |
GO:2000078 | positive regulation of type B pancreatic cell development | 9.764654e-6 |
GO:0070252 | actin-mediated cell contraction | 1.077271e-5 |
GO:0042921 | glucocorticoid receptor signaling pathway | 1.169679e-5 |
GO:0031396 | regulation of protein ubiquitination | 1.182858e-5 |
GO:0031958 | corticosteroid receptor signaling pathway | 1.200230e-5 |
GO:0009987 | cellular process | 1.251948e-5 |
GO:0050896 | response to stimulus | 1.346627e-5 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 1.455426e-5 |
GO:0003008 | system process | 1.456164e-5 |
GO:0051208 | sequestering of calcium ion | 1.659451e-5 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.715824e-5 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 1.727487e-5 |
GO:0030260 | entry into host cell | 2.327631e-5 |
GO:0006403 | RNA localization | 2.688764e-5 |
GO:0071731 | response to nitric oxide | 2.704346e-5 |
GO:0051276 | chromosome organization | 2.930354e-5 |
GO:0071241 | cellular response to inorganic substance | 2.966572e-5 |
GO:0048738 | cardiac muscle tissue development | 3.090000e-5 |
GO:0010035 | response to inorganic substance | 3.189698e-5 |
GO:0045214 | sarcomere organization | 3.211798e-5 |
GO:0030154 | cell differentiation | 3.236154e-5 |
GO:0006826 | iron ion transport | 3.481299e-5 |
GO:0009888 | tissue development | 4.153692e-5 |
GO:0007088 | regulation of mitosis | 4.193847e-5 |
GO:0030049 | muscle filament sliding | 4.351679e-5 |
GO:0002017 | regulation of blood volume by renal aldosterone | 4.389070e-5 |
GO:0006422 | aspartyl-tRNA aminoacylation | 4.584570e-5 |
GO:0006399 | tRNA metabolic process | 4.717639e-5 |
GO:0055065 | metal ion homeostasis | 4.823789e-5 |
GO:0048747 | muscle fiber development | 4.873364e-5 |
GO:0071103 | DNA conformation change | 5.060822e-5 |
GO:0051220 | cytoplasmic sequestering of protein | 5.061227e-5 |
GO:0060301 | positive regulation of cytokine activity | 5.080590e-5 |
GO:0048869 | cellular developmental process | 5.565927e-5 |
GO:0031032 | actomyosin structure organization | 6.032722e-5 |
GO:0006875 | cellular metal ion homeostasis | 6.131834e-5 |
GO:0007398 | ectoderm development | 6.167836e-5 |
GO:0002522 | leukocyte migration involved in immune response | 6.281403e-5 |
GO:0050878 | regulation of body fluid levels | 6.504692e-5 |
GO:0030003 | cellular cation homeostasis | 6.837136e-5 |
GO:0030048 | actin filament-based movement | 6.865058e-5 |
GO:0006551 | leucine metabolic process | 7.451919e-5 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 7.656758e-5 |
GO:0007256 | activation of JNKK activity | 7.823516e-5 |
GO:0070741 | response to interleukin-6 | 7.987177e-5 |
GO:0090304 | nucleic acid metabolic process | 8.087893e-5 |
GO:0032423 | regulation of mismatch repair | 8.144681e-5 |
GO:2000074 | regulation of type B pancreatic cell development | 8.426898e-5 |
GO:0018293 | protein-FAD linkage | 8.732473e-5 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 8.732473e-5 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 8.849853e-5 |
GO:0055002 | striated muscle cell development | 9.096194e-5 |
GO:0055008 | cardiac muscle tissue morphogenesis | 9.644759e-5 |
GO:0033198 | response to ATP | 9.829132e-5 |
GO:0021636 | trigeminal nerve morphogenesis | 9.909770e-5 |
GO:0048935 | peripheral nervous system neuron development | 1.063810e-4 |
GO:0003215 | cardiac right ventricle morphogenesis | 1.150355e-4 |
GO:0006665 | sphingolipid metabolic process | 1.155174e-4 |
GO:0010966 | regulation of phosphate transport | 1.184238e-4 |
GO:0007010 | cytoskeleton organization | 1.200123e-4 |
GO:0051488 | activation of anaphase-promoting complex activity | 1.314164e-4 |
GO:0003341 | cilium movement | 1.327655e-4 |
GO:0006707 | cholesterol catabolic process | 1.338772e-4 |
GO:0032425 | positive regulation of mismatch repair | 1.364411e-4 |
GO:0010524 | positive regulation of calcium ion transport into cytosol | 1.416906e-4 |
GO:0060413 | atrial septum morphogenesis | 1.582965e-4 |
GO:0055080 | cation homeostasis | 1.696814e-4 |
GO:0051901 | positive regulation of mitochondrial depolarization | 1.719663e-4 |
GO:0055093 | response to hyperoxia | 1.742876e-4 |
GO:0055001 | muscle cell development | 1.830203e-4 |
GO:0071347 | cellular response to interleukin-1 | 1.848132e-4 |
GO:0006766 | vitamin metabolic process | 1.867659e-4 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.874281e-4 |
GO:0034660 | ncRNA metabolic process | 1.892340e-4 |
GO:0070208 | protein heterotrimerization | 1.924519e-4 |
GO:0008211 | glucocorticoid metabolic process | 2.125898e-4 |
GO:0060415 | muscle tissue morphogenesis | 2.150613e-4 |
GO:0032417 | positive regulation of sodium:hydrogen antiporter activity | 2.250230e-4 |
GO:0014052 | regulation of gamma-aminobutyric acid secretion | 2.493649e-4 |
GO:0007413 | axonal fasciculation | 2.545134e-4 |
GO:0002407 | dendritic cell chemotaxis | 2.672608e-4 |
GO:0006643 | membrane lipid metabolic process | 2.712846e-4 |
GO:0030518 | steroid hormone receptor signaling pathway | 2.736020e-4 |
GO:0009605 | response to external stimulus | 2.754326e-4 |
GO:0043402 | glucocorticoid mediated signaling pathway | 2.820814e-4 |
GO:0051480 | cytosolic calcium ion homeostasis | 3.433057e-4 |
GO:0009617 | response to bacterium | 3.484312e-4 |
GO:0034120 | positive regulation of erythrocyte aggregation | 3.536496e-4 |
GO:0051235 | maintenance of location | 3.756734e-4 |
GO:0043982 | histone H4-K8 acetylation | 3.885314e-4 |
GO:0043981 | histone H4-K5 acetylation | 3.885314e-4 |
GO:0007250 | activation of NF-kappaB-inducing kinase activity | 3.900754e-4 |
GO:0006968 | cellular defense response | 3.989549e-4 |
GO:0048549 | positive regulation of pinocytosis | 4.215970e-4 |
GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 4.215970e-4 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 4.296263e-4 |
GO:0019438 | aromatic compound biosynthetic process | 4.330033e-4 |
GO:0019882 | antigen processing and presentation | 4.341633e-4 |
GO:0060300 | regulation of cytokine activity | 4.349164e-4 |
GO:0032501 | multicellular organismal process | 4.541317e-4 |
GO:0010948 | negative regulation of cell cycle process | 4.636381e-4 |
GO:0071230 | cellular response to amino acid stimulus | 4.710343e-4 |
GO:0022614 | membrane to membrane docking | 4.766220e-4 |
GO:0070206 | protein trimerization | 4.906069e-4 |
GO:0014706 | striated muscle tissue development | 5.019165e-4 |
GO:0071299 | cellular response to vitamin A | 5.171393e-4 |
GO:0003283 | atrial septum development | 5.195056e-4 |
GO:0015671 | oxygen transport | 5.201244e-4 |
GO:0033189 | response to vitamin A | 5.414618e-4 |
GO:0085029 | extracellular matrix assembly | 5.661043e-4 |
GO:0032507 | maintenance of protein location in cell | 5.683214e-4 |
GO:0007136 | meiotic prophase II | 5.683421e-4 |
GO:0042427 | serotonin biosynthetic process | 5.711071e-4 |
GO:0032502 | developmental process | 6.241989e-4 |
GO:0046519 | sphingoid metabolic process | 6.281230e-4 |
GO:0006672 | ceramide metabolic process | 6.580674e-4 |
GO:0035590 | purinergic nucleotide receptor signaling pathway | 7.163176e-4 |
GO:0032203 | telomere formation via telomerase | 7.170011e-4 |
GO:0003017 | lymph circulation | 7.259973e-4 |
GO:0009635 | response to herbicide | 7.379672e-4 |
GO:0001957 | intramembranous ossification | 7.669570e-4 |
GO:0050900 | leukocyte migration | 7.854677e-4 |
GO:0031344 | regulation of cell projection organization | 8.057429e-4 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 8.519162e-4 |
GO:0032963 | collagen metabolic process | 8.597876e-4 |
GO:0043116 | negative regulation of vascular permeability | 8.683972e-4 |
GO:0032308 | positive regulation of prostaglandin secretion | 8.705075e-4 |
GO:0032861 | activation of Rap GTPase activity | 9.039800e-4 |
GO:0015758 | glucose transport | 9.142904e-4 |
GO:0015931 | nucleobase-containing compound transport | 9.197160e-4 |
GO:0071285 | cellular response to lithium ion | 9.245927e-4 |
GO:0070634 | transepithelial ammonium transport | 9.271625e-4 |
GO:0003211 | cardiac ventricle formation | 9.318287e-4 |
GO:0030574 | collagen catabolic process | 9.350409e-4 |
GO:0071300 | cellular response to retinoic acid | 9.630111e-4 |
GO:0048644 | muscle organ morphogenesis | 9.633840e-4 |
GO:0033523 | histone H2B ubiquitination | 9.710105e-4 |
GO:0045070 | positive regulation of viral genome replication | 9.933066e-4 |
GO:0006508 | proteolysis | 9.973647e-4 |
GO:0002237 | response to molecule of bacterial origin | 1.000438e-3 |
GO:0008645 | hexose transport | 1.009021e-3 |
GO:0030522 | intracellular receptor mediated signaling pathway | 1.038808e-3 |
GO:0001560 | regulation of cell growth by extracellular stimulus | 1.044321e-3 |
GO:0015749 | monosaccharide transport | 1.059533e-3 |
GO:0071286 | cellular response to magnesium ion | 1.061023e-3 |
GO:0007159 | leukocyte cell-cell adhesion | 1.077086e-3 |
GO:0044241 | lipid digestion | 1.114196e-3 |
GO:0051930 | regulation of sensory perception of pain | 1.118526e-3 |
GO:0007623 | circadian rhythm | 1.121680e-3 |
GO:0006704 | glucocorticoid biosynthetic process | 1.147875e-3 |
GO:0071418 | cellular response to amine stimulus | 1.154328e-3 |
GO:0033572 | transferrin transport | 1.200598e-3 |
GO:0030163 | protein catabolic process | 1.203679e-3 |
GO:0003209 | cardiac atrium morphogenesis | 1.206988e-3 |
GO:0014048 | regulation of glutamate secretion | 1.206988e-3 |
GO:0070375 | BMK cascade | 1.210587e-3 |
GO:0015942 | formate metabolic process | 1.210587e-3 |
GO:0071460 | cellular response to cell-matrix adhesion | 1.210744e-3 |
GO:0048513 | organ development | 1.211930e-3 |
GO:0006026 | aminoglycan catabolic process | 1.211978e-3 |
GO:0007585 | respiratory gaseous exchange | 1.233142e-3 |
GO:0071295 | cellular response to vitamin | 1.236015e-3 |
GO:0065008 | regulation of biological quality | 1.247637e-3 |
GO:0042558 | pteridine-containing compound metabolic process | 1.284953e-3 |
GO:0007219 | Notch signaling pathway | 1.297791e-3 |
GO:0071417 | cellular response to organic nitrogen | 1.304979e-3 |
GO:0048548 | regulation of pinocytosis | 1.307423e-3 |
GO:0043132 | NAD transport | 1.311565e-3 |
GO:0040040 | thermosensory behavior | 1.318415e-3 |
GO:0033273 | response to vitamin | 1.324476e-3 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.350543e-3 |
GO:0090277 | positive regulation of peptide hormone secretion | 1.407284e-3 |
GO:0003323 | type B pancreatic cell development | 1.408770e-3 |
GO:0030007 | cellular potassium ion homeostasis | 1.433419e-3 |
GO:0060537 | muscle tissue development | 1.444074e-3 |
GO:0006032 | chitin catabolic process | 1.456934e-3 |
GO:0043217 | myelin maintenance | 1.456934e-3 |
GO:0006396 | RNA processing | 1.463162e-3 |
GO:0006700 | C21-steroid hormone biosynthetic process | 1.471258e-3 |
GO:0070271 | protein complex biogenesis | 1.502350e-3 |
GO:0071229 | cellular response to acid | 1.525966e-3 |
GO:0007270 | neuron-neuron synaptic transmission | 1.557444e-3 |
GO:0015669 | gas transport | 1.566123e-3 |
GO:0042098 | T cell proliferation | 1.576981e-3 |
GO:0002793 | positive regulation of peptide secretion | 1.610948e-3 |
GO:0014054 | positive regulation of gamma-aminobutyric acid secretion | 1.616430e-3 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 1.616430e-3 |
GO:0000296 | spermine transport | 1.616430e-3 |
GO:0051146 | striated muscle cell differentiation | 1.672536e-3 |
GO:0070849 | response to epidermal growth factor stimulus | 1.678900e-3 |
GO:0071496 | cellular response to external stimulus | 1.725615e-3 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 1.759588e-3 |
GO:0042692 | muscle cell differentiation | 1.772831e-3 |
GO:0015991 | ATP hydrolysis coupled proton transport | 1.786969e-3 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 1.789572e-3 |
GO:0047496 | vesicle transport along microtubule | 1.790424e-3 |
GO:0034644 | cellular response to UV | 1.860592e-3 |
GO:0006461 | protein complex assembly | 1.889264e-3 |
GO:0044257 | cellular protein catabolic process | 1.904286e-3 |
GO:0030199 | collagen fibril organization | 1.921380e-3 |
GO:0048730 | epidermis morphogenesis | 1.922624e-3 |
GO:0090276 | regulation of peptide hormone secretion | 1.942485e-3 |
GO:0032024 | positive regulation of insulin secretion | 1.974552e-3 |
GO:0045185 | maintenance of protein location | 1.974733e-3 |
GO:0070734 | histone H3-K27 methylation | 1.975908e-3 |
GO:0030299 | intestinal cholesterol absorption | 1.979294e-3 |
GO:0032892 | positive regulation of organic acid transport | 1.995664e-3 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 2.026688e-3 |
GO:0051238 | sequestering of metal ion | 2.068090e-3 |
GO:0031570 | DNA integrity checkpoint | 2.075185e-3 |
GO:0032320 | positive regulation of Ras GTPase activity | 2.118272e-3 |
GO:0042384 | cilium assembly | 2.121032e-3 |
GO:0032854 | positive regulation of Rap GTPase activity | 2.127558e-3 |
GO:0051928 | positive regulation of calcium ion transport | 2.164475e-3 |
GO:0043983 | histone H4-K12 acetylation | 2.170242e-3 |
GO:0007599 | hemostasis | 2.172864e-3 |
GO:0003230 | cardiac atrium development | 2.204433e-3 |
GO:0002791 | regulation of peptide secretion | 2.221079e-3 |
GO:0046578 | regulation of Ras protein signal transduction | 2.239464e-3 |
GO:0010038 | response to metal ion | 2.243133e-3 |
GO:0022417 | protein maturation by protein folding | 2.291648e-3 |
GO:0043632 | modification-dependent macromolecule catabolic process | 2.297247e-3 |
GO:0051651 | maintenance of location in cell | 2.297657e-3 |
GO:0006259 | DNA metabolic process | 2.323475e-3 |
GO:0044282 | small molecule catabolic process | 2.460367e-3 |
GO:2000124 | regulation of endocannabinoid signaling pathway | 2.465716e-3 |
GO:0050796 | regulation of insulin secretion | 2.510788e-3 |
GO:0006874 | cellular calcium ion homeostasis | 2.559510e-3 |
GO:0007601 | visual perception | 2.568773e-3 |
GO:0006706 | steroid catabolic process | 2.587076e-3 |
GO:0044254 | multicellular organismal protein catabolic process | 2.619901e-3 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 2.630224e-3 |
GO:0050717 | positive regulation of interleukin-1 alpha secretion | 2.630224e-3 |
GO:0021854 | hypothalamus development | 2.634699e-3 |
GO:0071248 | cellular response to metal ion | 2.655628e-3 |
GO:0043968 | histone H2A acetylation | 2.685804e-3 |
GO:0042559 | pteridine-containing compound biosynthetic process | 2.698338e-3 |
GO:0045815 | positive regulation of gene expression, epigenetic | 2.770748e-3 |
GO:0050953 | sensory perception of light stimulus | 2.794056e-3 |
GO:0043248 | proteasome assembly | 2.796507e-3 |
GO:0014745 | negative regulation of muscle adaptation | 2.843416e-3 |
GO:0034612 | response to tumor necrosis factor | 2.847612e-3 |
GO:0048251 | elastic fiber assembly | 2.899127e-3 |
GO:0032496 | response to lipopolysaccharide | 2.934516e-3 |
GO:0031943 | regulation of glucocorticoid metabolic process | 2.985304e-3 |
GO:2000193 | positive regulation of fatty acid transport | 2.985304e-3 |
GO:0019987 | negative regulation of anti-apoptosis | 2.986877e-3 |
GO:0007596 | blood coagulation | 3.133122e-3 |
GO:0000077 | DNA damage checkpoint | 3.139258e-3 |
GO:0046883 | regulation of hormone secretion | 3.171872e-3 |
GO:0043623 | cellular protein complex assembly | 3.240829e-3 |
GO:0043949 | regulation of cAMP-mediated signaling | 3.242979e-3 |
GO:0090231 | regulation of spindle checkpoint | 3.243687e-3 |
GO:0006767 | water-soluble vitamin metabolic process | 3.280338e-3 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 3.281803e-3 |
GO:0051017 | actin filament bundle assembly | 3.305511e-3 |
GO:0014049 | positive regulation of glutamate secretion | 3.318243e-3 |
GO:0051709 | regulation of killing of cells of other organism | 3.322366e-3 |
GO:0044268 | multicellular organismal protein metabolic process | 3.403676e-3 |
GO:0070560 | protein secretion by platelet | 3.403676e-3 |
GO:0060305 | regulation of cell diameter | 3.403676e-3 |
GO:0030845 | inhibition of phospholipase C activity involved in G-protein coupled receptor signaling pathway | 3.403676e-3 |
GO:0010920 | negative regulation of inositol phosphate biosynthetic process | 3.403676e-3 |
GO:0010925 | positive regulation of inositol-polyphosphate 5-phosphatase activity | 3.403676e-3 |
GO:0044154 | histone H3-K14 acetylation | 3.403676e-3 |
GO:0019233 | sensory perception of pain | 3.408687e-3 |
GO:0019059 | initiation of viral infection | 3.411185e-3 |
GO:0006937 | regulation of muscle contraction | 3.463864e-3 |
GO:0030218 | erythrocyte differentiation | 3.466618e-3 |
GO:0072503 | cellular divalent inorganic cation homeostasis | 3.470977e-3 |
GO:0030168 | platelet activation | 3.537222e-3 |
GO:0007205 | activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway | 3.543006e-3 |
GO:0044085 | cellular component biogenesis | 3.556528e-3 |
GO:0007016 | cytoskeletal anchoring at plasma membrane | 3.587418e-3 |
GO:0031670 | cellular response to nutrient | 3.604381e-3 |
GO:0007586 | digestion | 3.610155e-3 |
GO:0048729 | tissue morphogenesis | 3.639477e-3 |
GO:0044260 | cellular macromolecule metabolic process | 3.646852e-3 |
GO:0032415 | regulation of sodium:hydrogen antiporter activity | 3.698735e-3 |
GO:0051973 | positive regulation of telomerase activity | 3.712658e-3 |
GO:0018027 | peptidyl-lysine dimethylation | 3.726528e-3 |
GO:0001666 | response to hypoxia | 3.763659e-3 |
GO:0070493 | thrombin receptor signaling pathway | 3.927995e-3 |
GO:0090257 | regulation of muscle system process | 3.993883e-3 |
GO:0006935 | chemotaxis | 4.073801e-3 |
GO:0055074 | calcium ion homeostasis | 4.088787e-3 |
GO:0007443 | Malpighian tubule morphogenesis | 4.094766e-3 |
GO:0070367 | negative regulation of hepatocyte differentiation | 4.094766e-3 |
GO:0007155 | cell adhesion | 4.118769e-3 |
GO:0019941 | modification-dependent protein catabolic process | 4.129302e-3 |
GO:0071385 | cellular response to glucocorticoid stimulus | 4.216813e-3 |
GO:0007275 | multicellular organismal development | 4.235854e-3 |
GO:0045794 | negative regulation of cell volume | 4.237412e-3 |
GO:0009451 | RNA modification | 4.250321e-3 |
GO:0048485 | sympathetic nervous system development | 4.331645e-3 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 4.352227e-3 |
GO:0018026 | peptidyl-lysine monomethylation | 4.362141e-3 |
GO:0090232 | positive regulation of spindle checkpoint | 4.511393e-3 |
GO:0048699 | generation of neurons | 4.523482e-3 |
GO:0042074 | cell migration involved in gastrulation | 4.553412e-3 |
GO:0051028 | mRNA transport | 4.621766e-3 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 4.653163e-3 |
GO:0032730 | positive regulation of interleukin-1 alpha production | 4.653163e-3 |
GO:0046887 | positive regulation of hormone secretion | 4.673012e-3 |
GO:0022008 | neurogenesis | 4.738912e-3 |
GO:0008333 | endosome to lysosome transport | 4.818530e-3 |
GO:0048731 | system development | 4.826978e-3 |
GO:0060929 | atrioventricular node cell fate commitment | 4.842989e-3 |
GO:0060928 | atrioventricular node cell development | 4.842989e-3 |
GO:0003342 | proepicardium development | 4.842989e-3 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 4.842989e-3 |
GO:0022607 | cellular component assembly | 4.893929e-3 |
GO:0002376 | immune system process | 4.955785e-3 |
GO:0048843 | negative regulation of axon extension involved in axon guidance | 5.024903e-3 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 5.027614e-3 |
GO:0006879 | cellular iron ion homeostasis | 5.027614e-3 |
GO:0032383 | regulation of intracellular cholesterol transport | 5.155048e-3 |
GO:0021785 | branchiomotor neuron axon guidance | 5.155048e-3 |
GO:0043170 | macromolecule metabolic process | 5.190040e-3 |
GO:0014889 | muscle atrophy | 5.191196e-3 |
GO:0045739 | positive regulation of DNA repair | 5.287477e-3 |
GO:0006663 | platelet activating factor biosynthetic process | 5.357208e-3 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 5.376767e-3 |
GO:0010564 | regulation of cell cycle process | 5.389310e-3 |
GO:0007198 | inhibition of adenylate cyclase activity by serotonin receptor signaling pathway | 5.402657e-3 |
GO:0072507 | divalent inorganic cation homeostasis | 5.435326e-3 |
GO:0044242 | cellular lipid catabolic process | 5.492065e-3 |
GO:0031667 | response to nutrient levels | 5.562953e-3 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 5.668353e-3 |
GO:0007135 | meiosis II | 5.668353e-3 |
GO:0045664 | regulation of neuron differentiation | 5.716268e-3 |
GO:0046219 | indolalkylamine biosynthetic process | 5.738989e-3 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 5.738989e-3 |
GO:0014823 | response to activity | 5.750146e-3 |
GO:0030836 | positive regulation of actin filament depolymerization | 5.914201e-3 |
GO:0042107 | cytokine metabolic process | 6.122427e-3 |
GO:0032202 | telomere assembly | 6.208373e-3 |
GO:0048856 | anatomical structure development | 6.244575e-3 |
GO:0021522 | spinal cord motor neuron differentiation | 6.276397e-3 |
GO:0045859 | regulation of protein kinase activity | 6.285241e-3 |
GO:0070887 | cellular response to chemical stimulus | 6.292882e-3 |
GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 6.297010e-3 |
GO:0008628 | induction of apoptosis by hormones | 6.297010e-3 |
GO:0016032 | viral reproduction | 6.443583e-3 |
GO:0007289 | spermatid nucleus differentiation | 6.465860e-3 |
GO:0051452 | intracellular pH reduction | 6.519262e-3 |
GO:0043137 | DNA replication, removal of RNA primer | 6.572860e-3 |
GO:0065007 | biological regulation | 6.582384e-3 |
GO:0071495 | cellular response to endogenous stimulus | 6.645807e-3 |
GO:0070555 | response to interleukin-1 | 6.672001e-3 |
GO:0010517 | regulation of phospholipase activity | 6.680259e-3 |
GO:0055014 | atrial cardiac muscle cell development | 6.751155e-3 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 6.772523e-3 |
GO:0008038 | neuron recognition | 6.857648e-3 |
GO:0015031 | protein transport | 6.872203e-3 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 6.874604e-3 |
GO:0035090 | maintenance of apical/basal cell polarity | 6.874604e-3 |
GO:0006683 | galactosylceramide catabolic process | 6.874604e-3 |
GO:0031399 | regulation of protein modification process | 6.970928e-3 |
GO:0021761 | limbic system development | 7.036009e-3 |
GO:0030041 | actin filament polymerization | 7.060262e-3 |
GO:0051168 | nuclear export | 7.097469e-3 |
GO:0048096 | chromatin-mediated maintenance of transcription | 7.104196e-3 |
GO:0051707 | response to other organism | 7.107747e-3 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 7.197121e-3 |
GO:0050767 | regulation of neurogenesis | 7.322930e-3 |
GO:0009991 | response to extracellular stimulus | 7.439893e-3 |
GO:0061136 | regulation of proteasomal protein catabolic process | 7.477103e-3 |
GO:0008054 | cyclin catabolic process | 7.494975e-3 |
GO:0060841 | venous blood vessel development | 7.507223e-3 |
GO:0045666 | positive regulation of neuron differentiation | 7.519964e-3 |
GO:0007506 | gonadal mesoderm development | 7.522413e-3 |
GO:0003309 | type B pancreatic cell differentiation | 7.524730e-3 |
GO:0015872 | dopamine transport | 7.531805e-3 |
GO:0000041 | transition metal ion transport | 7.540298e-3 |
GO:0010639 | negative regulation of organelle organization | 7.587606e-3 |
GO:0046653 | tetrahydrofolate metabolic process | 7.629565e-3 |
GO:0071478 | cellular response to radiation | 7.679782e-3 |
GO:0035729 | cellular response to hepatocyte growth factor stimulus | 7.838798e-3 |
GO:0035435 | phosphate ion transmembrane transport | 7.845266e-3 |
GO:0071844 | cellular component assembly at cellular level | 7.950371e-3 |
GO:0007249 | I-kappaB kinase/NF-kappaB cascade | 7.974493e-3 |
GO:0031668 | cellular response to extracellular stimulus | 7.984058e-3 |
GO:0034465 | response to carbon monoxide | 8.013386e-3 |
GO:0007411 | axon guidance | 8.033010e-3 |
GO:0051701 | interaction with host | 8.068549e-3 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 8.169709e-3 |
GO:0006950 | response to stress | 8.187406e-3 |
GO:0033043 | regulation of organelle organization | 8.236447e-3 |
GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 8.250212e-3 |
GO:0065003 | macromolecular complex assembly | 8.397798e-3 |
GO:0042118 | endothelial cell activation | 8.447359e-3 |
GO:0010519 | negative regulation of phospholipase activity | 8.447359e-3 |
GO:0035587 | purinergic receptor signaling pathway | 8.467421e-3 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 8.480843e-3 |
GO:0045184 | establishment of protein localization | 8.514127e-3 |
GO:0010332 | response to gamma radiation | 8.518170e-3 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 8.599414e-3 |
GO:0045793 | positive regulation of cell size | 8.602477e-3 |
GO:0071526 | semaphorin-plexin signaling pathway | 8.608936e-3 |
GO:0010522 | regulation of calcium ion transport into cytosol | 8.854648e-3 |
GO:0007509 | mesoderm migration involved in gastrulation | 8.897918e-3 |
GO:0046164 | alcohol catabolic process | 8.905653e-3 |
GO:0034589 | hydroxyproline transport | 8.935609e-3 |
GO:0030263 | apoptotic chromosome condensation | 8.935609e-3 |
GO:0015826 | threonine transport | 8.935609e-3 |
GO:0042420 | dopamine catabolic process | 8.968578e-3 |
GO:0042094 | interleukin-2 biosynthetic process | 8.968578e-3 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 9.030114e-3 |
GO:0090317 | negative regulation of intracellular protein transport | 9.114447e-3 |
GO:0008207 | C21-steroid hormone metabolic process | 9.146603e-3 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 9.279367e-3 |
GO:0034220 | ion transmembrane transport | 9.318249e-3 |
GO:0060411 | cardiac septum morphogenesis | 9.332492e-3 |
GO:0045209 | MAPK phosphatase export from nucleus, leptomycin B sensitive | 9.368741e-3 |
GO:0045204 | MAPK export from nucleus | 9.368741e-3 |
GO:0010934 | macrophage cytokine production | 9.368741e-3 |
GO:0014909 | smooth muscle cell migration | 9.368741e-3 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 9.399383e-3 |
GO:0009062 | fatty acid catabolic process | 9.420116e-3 |
GO:0042060 | wound healing | 9.479037e-3 |
GO:0055082 | cellular chemical homeostasis | 9.590639e-3 |
GO:0060971 | embryonic heart tube left/right pattern formation | 9.778167e-3 |
GO:0060920 | pacemaker cell differentiation | 9.778167e-3 |
GO:0060402 | calcium ion transport into cytosol | 9.778589e-3 |
GO:0030185 | nitric oxide transport | 9.780123e-3 |
GO:0045851 | pH reduction | 9.832798e-3 |
GO:0042723 | thiamine-containing compound metabolic process | 9.850120e-3 |
GO:0051704 | multi-organism process | 9.945387e-3 |
GO:0032602 | chemokine production | 9.965300e-3 |
GO:0042997 | negative regulation of Golgi to plasma membrane protein transport | 9.965300e-3 |
GO:0009607 | response to biotic stimulus | 1.000011e-2 |
GO:0070482 | response to oxygen levels | 1.002812e-2 |
GO:0045988 | negative regulation of striated muscle contraction | 1.012357e-2 |
GO:0070588 | calcium ion transmembrane transport | 1.024683e-2 |
GO:0003357 | noradrenergic neuron differentiation | 1.036570e-2 |
GO:0044237 | cellular metabolic process | 1.040143e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006957 | complement activation, alternative pathway | 8.188721e-11 |
GO:0048240 | sperm capacitation | 1.023839e-10 |
GO:0002920 | regulation of humoral immune response | 1.703005e-10 |
GO:0043056 | forward locomotion | 3.290837e-10 |
GO:0002889 | regulation of immunoglobulin mediated immune response | 3.947778e-10 |
GO:0006958 | complement activation, classical pathway | 5.612969e-10 |
GO:0033058 | directional locomotion | 2.604118e-9 |
GO:0055003 | cardiac myofibril assembly | 9.176960e-9 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 1.422737e-8 |
GO:0006278 | RNA-dependent DNA replication | 1.670098e-8 |
GO:0021758 | putamen development | 3.356244e-8 |
GO:0021757 | caudate nucleus development | 3.356244e-8 |
GO:0001970 | positive regulation of activation of membrane attack complex | 4.088646e-8 |
GO:0002922 | positive regulation of humoral immune response | 5.624093e-8 |
GO:0001969 | regulation of activation of membrane attack complex | 9.286383e-8 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 1.160894e-7 |
GO:0071230 | cellular response to amino acid stimulus | 1.259643e-7 |
GO:0002253 | activation of immune response | 1.403162e-7 |
GO:0006956 | complement activation | 1.450864e-7 |
GO:0002449 | lymphocyte mediated immunity | 1.839514e-7 |
GO:0055114 | oxidation-reduction process | 2.020643e-7 |
GO:0001974 | blood vessel remodeling | 2.272425e-7 |
GO:0072376 | protein activation cascade | 2.591482e-7 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 2.890156e-7 |
GO:0071229 | cellular response to acid | 2.997750e-7 |
GO:0035674 | tricarboxylic acid transmembrane transport | 3.011831e-7 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 3.757868e-7 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 5.078928e-7 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 5.445323e-7 |
GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 5.836667e-7 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 6.740494e-7 |
GO:0006189 | 'de novo' IMP biosynthetic process | 6.759217e-7 |
GO:0002706 | regulation of lymphocyte mediated immunity | 6.974663e-7 |
GO:0002443 | leukocyte mediated immunity | 7.224080e-7 |
GO:0045087 | innate immune response | 7.835955e-7 |
GO:0006952 | defense response | 8.112102e-7 |
GO:0035634 | response to stilbenoid | 8.509316e-7 |
GO:0055013 | cardiac muscle cell development | 8.801261e-7 |
GO:0008588 | release of cytoplasmic sequestered NF-kappaB | 1.029338e-6 |
GO:0010954 | positive regulation of protein processing | 1.040526e-6 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 1.168943e-6 |
GO:0042297 | vocal learning | 1.284746e-6 |
GO:0050776 | regulation of immune response | 1.439373e-6 |
GO:0002819 | regulation of adaptive immune response | 1.479505e-6 |
GO:0050778 | positive regulation of immune response | 1.641646e-6 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 1.819292e-6 |
GO:0055006 | cardiac cell development | 2.111574e-6 |
GO:0071418 | cellular response to amine stimulus | 2.682567e-6 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 2.729709e-6 |
GO:0050777 | negative regulation of immune response | 2.763148e-6 |
GO:0019693 | ribose phosphate metabolic process | 2.774862e-6 |
GO:0002885 | positive regulation of hypersensitivity | 2.774862e-6 |
GO:0006164 | purine nucleotide biosynthetic process | 2.906287e-6 |
GO:0002883 | regulation of hypersensitivity | 3.130034e-6 |
GO:0019442 | tryptophan catabolic process to acetyl-CoA | 3.347865e-6 |
GO:0015746 | citrate transport | 3.347865e-6 |
GO:0071417 | cellular response to organic nitrogen | 3.492507e-6 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 3.735880e-6 |
GO:0009987 | cellular process | 3.867725e-6 |
GO:0030199 | collagen fibril organization | 4.008590e-6 |
GO:0009115 | xanthine catabolic process | 4.671124e-6 |
GO:0015761 | mannose transport | 5.110326e-6 |
GO:0002252 | immune effector process | 5.580021e-6 |
GO:0006014 | D-ribose metabolic process | 6.434972e-6 |
GO:0071422 | succinate transmembrane transport | 6.709545e-6 |
GO:0071702 | organic substance transport | 7.817025e-6 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 8.750697e-6 |
GO:0006415 | translational termination | 1.073741e-5 |
GO:0072522 | purine-containing compound biosynthetic process | 1.082262e-5 |
GO:0016064 | immunoglobulin mediated immune response | 1.254064e-5 |
GO:0002821 | positive regulation of adaptive immune response | 1.302966e-5 |
GO:0006188 | IMP biosynthetic process | 1.331666e-5 |
GO:0050860 | negative regulation of T cell receptor signaling pathway | 1.364433e-5 |
GO:0070208 | protein heterotrimerization | 1.411892e-5 |
GO:0019724 | B cell mediated immunity | 1.457790e-5 |
GO:0009165 | nucleotide biosynthetic process | 1.489368e-5 |
GO:0002551 | mast cell chemotaxis | 1.492658e-5 |
GO:0030449 | regulation of complement activation | 1.680442e-5 |
GO:0002703 | regulation of leukocyte mediated immunity | 1.927973e-5 |
GO:0006144 | purine base metabolic process | 2.144735e-5 |
GO:0031223 | auditory behavior | 2.160123e-5 |
GO:0046110 | xanthine metabolic process | 2.285577e-5 |
GO:0034516 | response to vitamin B6 | 2.314490e-5 |
GO:0043420 | anthranilate metabolic process | 2.314490e-5 |
GO:0002699 | positive regulation of immune effector process | 2.468165e-5 |
GO:0006810 | transport | 2.627570e-5 |
GO:0002684 | positive regulation of immune system process | 3.159701e-5 |
GO:0019805 | quinolinate biosynthetic process | 3.425706e-5 |
GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 3.743425e-5 |
GO:0010886 | positive regulation of cholesterol storage | 4.082156e-5 |
GO:0009260 | ribonucleotide biosynthetic process | 4.106447e-5 |
GO:0060356 | leucine import | 4.182220e-5 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 4.294118e-5 |
GO:0031032 | actomyosin structure organization | 4.359282e-5 |
GO:0018125 | peptidyl-cysteine methylation | 4.512114e-5 |
GO:0031860 | telomeric 3' overhang formation | 4.512114e-5 |
GO:0060013 | righting reflex | 4.522476e-5 |
GO:0072560 | type B pancreatic cell maturation | 4.882674e-5 |
GO:0030239 | myofibril assembly | 5.022845e-5 |
GO:2000121 | regulation of removal of superoxide radicals | 5.069351e-5 |
GO:0002024 | diet induced thermogenesis | 5.155886e-5 |
GO:0009566 | fertilization | 5.365804e-5 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 5.535896e-5 |
GO:0006145 | purine base catabolic process | 6.687354e-5 |
GO:0007638 | mechanosensory behavior | 7.536109e-5 |
GO:0007286 | spermatid development | 7.792390e-5 |
GO:0050896 | response to stimulus | 8.223463e-5 |
GO:0009152 | purine ribonucleotide biosynthetic process | 8.331821e-5 |
GO:0044281 | small molecule metabolic process | 8.356572e-5 |
GO:0001101 | response to acid | 8.476282e-5 |
GO:0034421 | post-translational protein acetylation | 9.076283e-5 |
GO:0050766 | positive regulation of phagocytosis | 9.296609e-5 |
GO:0010883 | regulation of lipid storage | 9.686963e-5 |
GO:0031295 | T cell costimulation | 9.717827e-5 |
GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 9.717827e-5 |
GO:0002921 | negative regulation of humoral immune response | 9.874167e-5 |
GO:0033601 | positive regulation of mammary gland epithelial cell proliferation | 9.950799e-5 |
GO:0007512 | adult heart development | 1.078354e-4 |
GO:2000334 | positive regulation of blood microparticle formation | 1.090402e-4 |
GO:0015827 | tryptophan transport | 1.090402e-4 |
GO:0021756 | striatum development | 1.112703e-4 |
GO:0002675 | positive regulation of acute inflammatory response | 1.112703e-4 |
GO:0050764 | regulation of phagocytosis | 1.161471e-4 |
GO:0021544 | subpallium development | 1.212183e-4 |
GO:0006098 | pentose-phosphate shunt | 1.270171e-4 |
GO:0043200 | response to amino acid stimulus | 1.298709e-4 |
GO:0042990 | regulation of transcription factor import into nucleus | 1.368430e-4 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 1.564343e-4 |
GO:0010927 | cellular component assembly involved in morphogenesis | 1.597951e-4 |
GO:0043589 | skin morphogenesis | 1.604903e-4 |
GO:0051234 | establishment of localization | 1.667644e-4 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 1.682188e-4 |
GO:0010884 | positive regulation of lipid storage | 1.691597e-4 |
GO:0009074 | aromatic amino acid family catabolic process | 1.718095e-4 |
GO:0007595 | lactation | 1.793659e-4 |
GO:0055096 | low-density lipoprotein particle mediated signaling | 1.808621e-4 |
GO:0002820 | negative regulation of adaptive immune response | 1.867131e-4 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 1.955048e-4 |
GO:0070543 | response to linoleic acid | 1.955048e-4 |
GO:0034696 | response to prostaglandin F stimulus | 1.955048e-4 |
GO:0034014 | response to triglyceride | 1.955048e-4 |
GO:0006954 | inflammatory response | 2.015656e-4 |
GO:0009113 | purine base biosynthetic process | 2.020969e-4 |
GO:0043506 | regulation of JUN kinase activity | 2.027889e-4 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 2.316694e-4 |
GO:0019439 | aromatic compound catabolic process | 2.354069e-4 |
GO:0055002 | striated muscle cell development | 2.380978e-4 |
GO:0051716 | cellular response to stimulus | 2.413127e-4 |
GO:0050856 | regulation of T cell receptor signaling pathway | 2.535435e-4 |
GO:0046942 | carboxylic acid transport | 2.558024e-4 |
GO:0071447 | cellular response to hydroperoxide | 2.743847e-4 |
GO:0015911 | plasma membrane long-chain fatty acid transport | 2.743847e-4 |
GO:0010744 | positive regulation of macrophage derived foam cell differentiation | 2.849020e-4 |
GO:0034694 | response to prostaglandin stimulus | 2.950787e-4 |
GO:0045214 | sarcomere organization | 2.958203e-4 |
GO:0070371 | ERK1 and ERK2 cascade | 3.158686e-4 |
GO:0006457 | protein folding | 3.161849e-4 |
GO:0018208 | peptidyl-proline modification | 3.329152e-4 |
GO:0033194 | response to hydroperoxide | 3.544110e-4 |
GO:0046496 | nicotinamide nucleotide metabolic process | 3.619232e-4 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 3.674441e-4 |
GO:0060135 | maternal process involved in female pregnancy | 3.691888e-4 |
GO:0048515 | spermatid differentiation | 3.748537e-4 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 3.991389e-4 |
GO:0015849 | organic acid transport | 4.024920e-4 |
GO:0060100 | positive regulation of phagocytosis, engulfment | 4.070747e-4 |
GO:2000078 | positive regulation of type B pancreatic cell development | 4.431784e-4 |
GO:0034383 | low-density lipoprotein particle clearance | 4.472397e-4 |
GO:0006563 | L-serine metabolic process | 4.535084e-4 |
GO:0048840 | otolith development | 4.605560e-4 |
GO:0015820 | leucine transport | 4.605560e-4 |
GO:0010951 | negative regulation of endopeptidase activity | 4.606356e-4 |
GO:0010885 | regulation of cholesterol storage | 4.696841e-4 |
GO:0023052 | signaling | 4.758854e-4 |
GO:0006959 | humoral immune response | 4.849286e-4 |
GO:0043588 | skin development | 4.951264e-4 |
GO:0018130 | heterocycle biosynthetic process | 5.094969e-4 |
GO:0090074 | negative regulation of protein homodimerization activity | 5.294115e-4 |
GO:0014075 | response to amine stimulus | 5.531043e-4 |
GO:0043687 | post-translational protein modification | 5.639634e-4 |
GO:0042267 | natural killer cell mediated cytotoxicity | 5.639634e-4 |
GO:0060004 | reflex | 5.647190e-4 |
GO:0046622 | positive regulation of organ growth | 5.665216e-4 |
GO:0048857 | neural nucleus development | 5.665216e-4 |
GO:0050853 | B cell receptor signaling pathway | 5.712784e-4 |
GO:0019321 | pentose metabolic process | 5.714121e-4 |
GO:0003350 | pulmonary myocardium development | 5.905966e-4 |
GO:0015833 | peptide transport | 6.222344e-4 |
GO:0048245 | eosinophil chemotaxis | 6.269294e-4 |
GO:0030422 | production of siRNA involved in RNA interference | 6.269294e-4 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 6.269294e-4 |
GO:0043507 | positive regulation of JUN kinase activity | 6.276585e-4 |
GO:0010243 | response to organic nitrogen | 6.427753e-4 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 6.744375e-4 |
GO:0031627 | telomeric loop formation | 6.906394e-4 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 6.947530e-4 |
GO:0002720 | positive regulation of cytokine production involved in immune response | 7.139905e-4 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 7.287948e-4 |
GO:0002021 | response to dietary excess | 7.631886e-4 |
GO:0001954 | positive regulation of cell-matrix adhesion | 7.682023e-4 |
GO:0030072 | peptide hormone secretion | 7.755383e-4 |
GO:0010743 | regulation of macrophage derived foam cell differentiation | 7.908963e-4 |
GO:0055001 | muscle cell development | 8.291703e-4 |
GO:0002707 | negative regulation of lymphocyte mediated immunity | 8.540090e-4 |
GO:0010574 | regulation of vascular endothelial growth factor production | 8.555134e-4 |
GO:0045343 | regulation of MHC class I biosynthetic process | 8.589904e-4 |
GO:0016246 | RNA interference | 8.589904e-4 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 8.829155e-4 |
GO:0043090 | amino acid import | 8.844877e-4 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 8.914887e-4 |
GO:0019346 | transsulfuration | 9.094336e-4 |
GO:0019343 | cysteine biosynthetic process via cystathionine | 9.094336e-4 |
GO:0043418 | homocysteine catabolic process | 9.094336e-4 |
GO:0006535 | cysteine biosynthetic process from serine | 9.094336e-4 |
GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure | 9.094336e-4 |
GO:0046903 | secretion | 9.166434e-4 |
GO:0002250 | adaptive immune response | 9.271068e-4 |
GO:0050851 | antigen receptor-mediated signaling pathway | 9.275331e-4 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 9.346968e-4 |
GO:0007589 | body fluid secretion | 9.375306e-4 |
GO:0006725 | cellular aromatic compound metabolic process | 9.518661e-4 |
GO:0044062 | regulation of excretion | 9.524146e-4 |
GO:0019448 | L-cysteine catabolic process | 9.951271e-4 |
GO:0009435 | NAD biosynthetic process | 1.043607e-3 |
GO:0055007 | cardiac muscle cell differentiation | 1.067704e-3 |
GO:0035051 | cardiac cell differentiation | 1.112095e-3 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 1.125511e-3 |
GO:0046951 | ketone body biosynthetic process | 1.145732e-3 |
GO:0002673 | regulation of acute inflammatory response | 1.159484e-3 |
GO:0002125 | maternal aggressive behavior | 1.167616e-3 |
GO:0009117 | nucleotide metabolic process | 1.187172e-3 |
GO:0015031 | protein transport | 1.212757e-3 |
GO:0002790 | peptide secretion | 1.254963e-3 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 1.294015e-3 |
GO:0009954 | proximal/distal pattern formation | 1.303762e-3 |
GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis | 1.309231e-3 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 1.311603e-3 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 1.312055e-3 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 1.351363e-3 |
GO:0046483 | heterocycle metabolic process | 1.371478e-3 |
GO:0050433 | regulation of catecholamine secretion | 1.389974e-3 |
GO:0060742 | epithelial cell differentiation involved in prostate gland development | 1.390626e-3 |
GO:0030073 | insulin secretion | 1.412229e-3 |
GO:0007015 | actin filament organization | 1.416111e-3 |
GO:0019376 | galactolipid catabolic process | 1.457304e-3 |
GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation | 1.462198e-3 |
GO:0003008 | system process | 1.464546e-3 |
GO:0046103 | inosine biosynthetic process | 1.467660e-3 |
GO:0006154 | adenosine catabolic process | 1.467660e-3 |
GO:0060285 | ciliary cell motility | 1.493534e-3 |
GO:0035095 | behavioral response to nicotine | 1.493534e-3 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 1.503335e-3 |
GO:0002683 | negative regulation of immune system process | 1.516671e-3 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 1.562734e-3 |
GO:0009259 | ribonucleotide metabolic process | 1.606233e-3 |
GO:0021549 | cerebellum development | 1.616760e-3 |
GO:0060112 | generation of ovulation cycle rhythm | 1.630069e-3 |
GO:0001988 | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 1.630069e-3 |
GO:0007165 | signal transduction | 1.635044e-3 |
GO:0009123 | nucleoside monophosphate metabolic process | 1.648682e-3 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 1.725033e-3 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 1.732454e-3 |
GO:0001508 | regulation of action potential | 1.815936e-3 |
GO:0014866 | skeletal myofibril assembly | 1.847835e-3 |
GO:0019362 | pyridine nucleotide metabolic process | 1.923440e-3 |
GO:0002697 | regulation of immune effector process | 1.925876e-3 |
GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway | 1.970675e-3 |
GO:0007154 | cell communication | 2.058965e-3 |
GO:0035813 | regulation of renal sodium excretion | 2.061668e-3 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 2.090391e-3 |
GO:0043206 | fibril organization | 2.102975e-3 |
GO:0007264 | small GTPase mediated signal transduction | 2.115877e-3 |
GO:0045577 | regulation of B cell differentiation | 2.131281e-3 |
GO:0009112 | nucleobase metabolic process | 2.131281e-3 |
GO:0002682 | regulation of immune system process | 2.143593e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 2.202454e-3 |
GO:0070814 | hydrogen sulfide biosynthetic process | 2.202454e-3 |
GO:0046102 | inosine metabolic process | 2.202454e-3 |
GO:0009070 | serine family amino acid biosynthetic process | 2.292536e-3 |
GO:0009150 | purine ribonucleotide metabolic process | 2.321124e-3 |
GO:0006869 | lipid transport | 2.351082e-3 |
GO:0006566 | threonine metabolic process | 2.397577e-3 |
GO:0048469 | cell maturation | 2.416483e-3 |
GO:0070613 | regulation of protein processing | 2.521505e-3 |
GO:0006040 | amino sugar metabolic process | 2.556697e-3 |
GO:0006260 | DNA replication | 2.633499e-3 |
GO:0071985 | multivesicular body sorting pathway | 2.641388e-3 |
GO:0018101 | peptidyl-citrulline biosynthetic process from peptidyl-arginine | 2.641388e-3 |
GO:0046112 | nucleobase biosynthetic process | 2.675585e-3 |
GO:0043624 | cellular protein complex disassembly | 2.675585e-3 |
GO:0060627 | regulation of vesicle-mediated transport | 2.677081e-3 |
GO:0070899 | mitochondrial tRNA wobble uridine modification | 2.686701e-3 |
GO:0019374 | galactolipid metabolic process | 2.700135e-3 |
GO:0045830 | positive regulation of isotype switching | 2.703780e-3 |
GO:0002757 | immune response-activating signal transduction | 2.740635e-3 |
GO:0019835 | cytolysis | 2.755420e-3 |
GO:0006706 | steroid catabolic process | 2.755420e-3 |
GO:0000413 | protein peptidyl-prolyl isomerization | 2.761303e-3 |
GO:0006835 | dicarboxylic acid transport | 2.764604e-3 |
GO:0006739 | NADP metabolic process | 2.811529e-3 |
GO:0071221 | cellular response to bacterial lipopeptide | 2.825206e-3 |
GO:0044273 | sulfur compound catabolic process | 2.966195e-3 |
GO:0008152 | metabolic process | 3.000623e-3 |
GO:0006565 | L-serine catabolic process | 3.130565e-3 |
GO:0006811 | ion transport | 3.146474e-3 |
GO:0006163 | purine nucleotide metabolic process | 3.287241e-3 |
GO:0046634 | regulation of alpha-beta T cell activation | 3.410553e-3 |
GO:0006955 | immune response | 3.419171e-3 |
GO:0050729 | positive regulation of inflammatory response | 3.471149e-3 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 3.486116e-3 |
GO:0071216 | cellular response to biotic stimulus | 3.508877e-3 |
GO:0032891 | negative regulation of organic acid transport | 3.559685e-3 |
GO:0046466 | membrane lipid catabolic process | 3.577508e-3 |
GO:0009072 | aromatic amino acid family metabolic process | 3.577508e-3 |
GO:0043241 | protein complex disassembly | 3.587185e-3 |
GO:0044130 | negative regulation of growth of symbiont in host | 3.592240e-3 |
GO:0044242 | cellular lipid catabolic process | 3.601906e-3 |
GO:0007527 | adult somatic muscle development | 3.620550e-3 |
GO:0007191 | activation of adenylate cyclase activity by dopamine receptor signaling pathway | 3.620550e-3 |
GO:0010046 | response to mycotoxin | 3.671726e-3 |
GO:0009791 | post-embryonic development | 3.717922e-3 |
GO:0001502 | cartilage condensation | 3.844555e-3 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 4.012652e-3 |
GO:0022037 | metencephalon development | 4.114236e-3 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 4.123135e-3 |
GO:0045911 | positive regulation of DNA recombination | 4.160495e-3 |
GO:0048730 | epidermis morphogenesis | 4.234324e-3 |
GO:0072521 | purine-containing compound metabolic process | 4.292927e-3 |
GO:0002764 | immune response-regulating signaling pathway | 4.298285e-3 |
GO:0021707 | cerebellar granule cell differentiation | 4.332114e-3 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 4.354768e-3 |
GO:0003341 | cilium movement | 4.366418e-3 |
GO:0002711 | positive regulation of T cell mediated immunity | 4.378424e-3 |
GO:0045184 | establishment of protein localization | 4.460336e-3 |
GO:0002700 | regulation of production of molecular mediator of immune response | 4.480369e-3 |
GO:0002726 | positive regulation of T cell cytokine production | 4.498607e-3 |
GO:0019441 | tryptophan catabolic process to kynurenine | 4.629731e-3 |
GO:0046635 | positive regulation of alpha-beta T cell activation | 4.689583e-3 |
GO:0002067 | glandular epithelial cell differentiation | 4.717562e-3 |
GO:0007613 | memory | 4.720806e-3 |
GO:0050667 | homocysteine metabolic process | 4.775416e-3 |
GO:0060296 | regulation of cilium beat frequency involved in ciliary motility | 4.775416e-3 |
GO:0010817 | regulation of hormone levels | 4.868067e-3 |
GO:0034224 | cellular response to zinc ion starvation | 4.916325e-3 |
GO:0019240 | citrulline biosynthetic process | 4.916325e-3 |
GO:0046328 | regulation of JNK cascade | 4.921002e-3 |
GO:0090322 | regulation of superoxide metabolic process | 4.929364e-3 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 4.941344e-3 |
GO:0042953 | lipoprotein transport | 5.013602e-3 |
GO:0046879 | hormone secretion | 5.186370e-3 |
GO:0045618 | positive regulation of keratinocyte differentiation | 5.209359e-3 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 5.221727e-3 |
GO:0015807 | L-amino acid transport | 5.221727e-3 |
GO:0015711 | organic anion transport | 5.225858e-3 |
GO:0010871 | negative regulation of receptor biosynthetic process | 5.258574e-3 |
GO:0009914 | hormone transport | 5.462260e-3 |
GO:0071896 | protein localization to adherens junction | 5.518085e-3 |
GO:0048732 | gland development | 5.561874e-3 |
GO:0034143 | regulation of toll-like receptor 4 signaling pathway | 5.607755e-3 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 5.616495e-3 |
GO:0006572 | tyrosine catabolic process | 5.668904e-3 |
GO:0046950 | cellular ketone body metabolic process | 5.668904e-3 |
GO:0006865 | amino acid transport | 5.709022e-3 |
GO:0006029 | proteoglycan metabolic process | 5.745657e-3 |
GO:0050864 | regulation of B cell activation | 5.780325e-3 |
GO:0021683 | cerebellar granular layer morphogenesis | 5.966151e-3 |
GO:0032793 | positive regulation of CREB transcription factor activity | 5.966151e-3 |
GO:0034381 | plasma lipoprotein particle clearance | 5.974416e-3 |
GO:0030198 | extracellular matrix organization | 5.992582e-3 |
GO:0032844 | regulation of homeostatic process | 5.993607e-3 |
GO:0070206 | protein trimerization | 6.003635e-3 |
GO:0021700 | developmental maturation | 6.097454e-3 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 6.154693e-3 |
GO:0031848 | protection from non-homologous end joining at telomere | 6.386591e-3 |
GO:0045061 | thymic T cell selection | 6.403485e-3 |
GO:0046320 | regulation of fatty acid oxidation | 6.543627e-3 |
GO:0010460 | positive regulation of heart rate | 6.543627e-3 |
GO:0046321 | positive regulation of fatty acid oxidation | 6.551902e-3 |
GO:0043901 | negative regulation of multi-organism process | 6.591068e-3 |
GO:0030903 | notochord development | 6.617968e-3 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 6.617968e-3 |
GO:0010172 | embryonic body morphogenesis | 6.617968e-3 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 6.717106e-3 |
GO:0000018 | regulation of DNA recombination | 6.717383e-3 |
GO:0018195 | peptidyl-arginine modification | 6.727945e-3 |
GO:0035556 | intracellular signal transduction | 6.734010e-3 |
GO:0016042 | lipid catabolic process | 6.752145e-3 |
GO:0006044 | N-acetylglucosamine metabolic process | 6.787614e-3 |
GO:0006887 | exocytosis | 6.791926e-3 |
GO:0046039 | GTP metabolic process | 6.826412e-3 |
GO:0032680 | regulation of tumor necrosis factor production | 6.827261e-3 |
GO:0032760 | positive regulation of tumor necrosis factor production | 6.928177e-3 |
GO:0034220 | ion transmembrane transport | 6.934923e-3 |
GO:0045923 | positive regulation of fatty acid metabolic process | 7.013274e-3 |
GO:0006013 | mannose metabolic process | 7.054169e-3 |
GO:0007257 | activation of JUN kinase activity | 7.129797e-3 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 7.134044e-3 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 7.165618e-3 |
GO:0031998 | regulation of fatty acid beta-oxidation | 7.170977e-3 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 7.207484e-3 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 7.209400e-3 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 7.209400e-3 |
GO:0048936 | peripheral nervous system neuron axonogenesis | 7.276329e-3 |
GO:0000963 | mitochondrial RNA processing | 7.276329e-3 |
GO:0045191 | regulation of isotype switching | 7.385960e-3 |
GO:0006171 | cAMP biosynthetic process | 7.459964e-3 |
GO:0045807 | positive regulation of endocytosis | 7.691579e-3 |
GO:0050878 | regulation of body fluid levels | 7.704032e-3 |
GO:0045606 | positive regulation of epidermal cell differentiation | 7.775684e-3 |
GO:0034121 | regulation of toll-like receptor signaling pathway | 7.795013e-3 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 7.972570e-3 |
GO:0033523 | histone H2B ubiquitination | 7.991294e-3 |
GO:0010876 | lipid localization | 8.001371e-3 |
GO:0042446 | hormone biosynthetic process | 8.079896e-3 |
GO:0022616 | DNA strand elongation | 8.092064e-3 |
GO:0008203 | cholesterol metabolic process | 8.100491e-3 |
GO:0060174 | limb bud formation | 8.170292e-3 |
GO:0032673 | regulation of interleukin-4 production | 8.170292e-3 |
GO:0043277 | apoptotic cell clearance | 8.187391e-3 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 8.190237e-3 |
GO:0006694 | steroid biosynthetic process | 8.267261e-3 |
GO:0030240 | skeletal muscle thin filament assembly | 8.378593e-3 |
GO:0014048 | regulation of glutamate secretion | 8.418735e-3 |
GO:0050870 | positive regulation of T cell activation | 8.420232e-3 |
GO:0030879 | mammary gland development | 8.708356e-3 |
GO:0014706 | striated muscle tissue development | 8.711310e-3 |
GO:0071223 | cellular response to lipoteichoic acid | 8.920387e-3 |
GO:0006568 | tryptophan metabolic process | 8.920387e-3 |
GO:0046085 | adenosine metabolic process | 8.920387e-3 |
GO:0035815 | positive regulation of renal sodium excretion | 8.998556e-3 |
GO:0051639 | actin filament network formation | 9.035509e-3 |
GO:0046395 | carboxylic acid catabolic process | 9.095896e-3 |
GO:0050679 | positive regulation of epithelial cell proliferation | 9.099641e-3 |
GO:0070918 | production of small RNA involved in gene silencing by RNA | 9.255802e-3 |
GO:0070189 | kynurenine metabolic process | 9.411750e-3 |
GO:0032769 | negative regulation of monooxygenase activity | 9.411750e-3 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 9.595840e-3 |
GO:0007608 | sensory perception of smell | 9.656262e-3 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 9.665406e-3 |
GO:0034122 | negative regulation of toll-like receptor signaling pathway | 9.665406e-3 |
GO:0014059 | regulation of dopamine secretion | 9.665406e-3 |
GO:0006910 | phagocytosis, recognition | 9.729366e-3 |
GO:0060525 | prostate glandular acinus development | 9.748104e-3 |
GO:0012502 | induction of programmed cell death | 9.957534e-3 |
GO:0006909 | phagocytosis | 1.001609e-2 |
GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis | 1.003194e-2 |
GO:0042713 | sperm ejaculation | 1.004056e-2 |
GO:0003309 | type B pancreatic cell differentiation | 1.008775e-2 |
GO:0080135 | regulation of cellular response to stress | 1.012373e-2 |
GO:0050996 | positive regulation of lipid catabolic process | 1.013139e-2 |
GO:0050863 | regulation of T cell activation | 1.026461e-2 |
GO:0006352 | transcription initiation, DNA-dependent | 1.033252e-2 |
GO:0060529 | squamous basal epithelial stem cell differentiation involved in prostate gland acinus development | 1.034032e-2 |
GO:0009448 | gamma-aminobutyric acid metabolic process | 1.034032e-2 |
GO:0006613 | cotranslational protein targeting to membrane | 1.034032e-2 |
GO:0001909 | leukocyte mediated cytotoxicity | 1.046130e-2 |
GO:0050852 | T cell receptor signaling pathway | 1.073139e-2 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.092080e-2 |
GO:0016098 | monoterpenoid metabolic process | 1.110794e-2 |
GO:0048302 | regulation of isotype switching to IgG isotypes | 1.114407e-2 |
GO:0007274 | neuromuscular synaptic transmission | 1.114407e-2 |
GO:0045616 | regulation of keratinocyte differentiation | 1.114407e-2 |
GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 1.123244e-2 |
GO:0017157 | regulation of exocytosis | 1.133892e-2 |
GO:0006754 | ATP biosynthetic process | 1.137345e-2 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 1.144249e-2 |
GO:0006983 | ER overload response | 1.163306e-2 |
GO:0008202 | steroid metabolic process | 1.177970e-2 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 1.179644e-2 |
GO:0000733 | DNA strand renaturation | 1.180505e-2 |
GO:0006559 | L-phenylalanine catabolic process | 1.180505e-2 |
GO:0006702 | androgen biosynthetic process | 1.190853e-2 |
GO:0021575 | hindbrain morphogenesis | 1.198855e-2 |
GO:0045780 | positive regulation of bone resorption | 1.200878e-2 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 1.204391e-2 |
GO:0003180 | aortic valve morphogenesis | 1.214919e-2 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 1.218011e-2 |
GO:0060749 | mammary gland alveolus development | 1.219612e-2 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 1.223828e-2 |
GO:0007499 | ectoderm and mesoderm interaction | 1.223828e-2 |
GO:0032753 | positive regulation of interleukin-4 production | 1.239756e-2 |
GO:0048304 | positive regulation of isotype switching to IgG isotypes | 1.246511e-2 |
GO:0009069 | serine family amino acid metabolic process | 1.253158e-2 |
GO:0006564 | L-serine biosynthetic process | 1.258470e-2 |
GO:0072086 | specification of loop of Henle identity | 1.258470e-2 |
GO:0000959 | mitochondrial RNA metabolic process | 1.258470e-2 |
GO:0051179 | localization | 1.275106e-2 |
GO:0006917 | induction of apoptosis | 1.301561e-2 |
GO:0007166 | cell surface receptor linked signaling pathway | 1.307364e-2 |
GO:0051952 | regulation of amine transport | 1.318030e-2 |
GO:0032846 | positive regulation of homeostatic process | 1.326947e-2 |
GO:0046058 | cAMP metabolic process | 1.327804e-2 |
GO:0060537 | muscle tissue development | 1.332798e-2 |
GO:0032768 | regulation of monooxygenase activity | 1.335419e-2 |
GO:0006534 | cysteine metabolic process | 1.338068e-2 |
GO:0021681 | cerebellar granular layer development | 1.338068e-2 |
GO:0006558 | L-phenylalanine metabolic process | 1.339647e-2 |
GO:0046340 | diacylglycerol catabolic process | 1.343214e-2 |
GO:0019344 | cysteine biosynthetic process | 1.343214e-2 |
GO:0030046 | parallel actin filament bundle assembly | 1.343214e-2 |